Discovering naturally processed antigenic determinants that confer protective T cell immunity
Pavlo Gilchuk(AstraZeneca (Japan)), Sebastian Joyce(Walther Cancer Foundation), Alessandro Sette(La Jolla Institute for Immunology), Stephanie B. Conant(Vanderbilt University), Xinnan Niu(Vanderbilt University), Charles T. Spencer(The University of Texas at El Paso), Timothy Hill(Vanderbilt University), Sine Reker Hadrup(Herlev Hospital), K. Jill McAfee(Vanderbilt University), Kathryn M. Edwards(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), William H. Hildebrand(University of Oklahoma Health Sciences Center), John J. Erickson(Vanderbilt University), Andrew J. Link(Vanderbilt University), John V. Williams(University of Wisconsin–Madison), Carla Oseroff(La Jolla Institute for Immunology), Mu Zheng(Vanderbilt University), Jennifer J. Gray(Vanderbilt University), Kelli L. Boyd(Vanderbilt University Medical Center), Ton N. Schumacher(Leiden University Medical Center), Jack R. Bennink(National Institutes of Health), Søren Buus(University of Copenhagen)
Cited by 83
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
The Burden of Respiratory Syncytial Virus Infection in Young Children
|New England Journal of Medicine|2009|2.3k